AR100926A1 - IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA - Google Patents
IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIAInfo
- Publication number
- AR100926A1 AR100926A1 ARP150101983A ARP150101983A AR100926A1 AR 100926 A1 AR100926 A1 AR 100926A1 AR P150101983 A ARP150101983 A AR P150101983A AR P150101983 A ARP150101983 A AR P150101983A AR 100926 A1 AR100926 A1 AR 100926A1
- Authority
- AR
- Argentina
- Prior art keywords
- lymphaide
- leukemia
- blood
- refers
- tumors
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente se refiere a péptidos, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, se refiere a la inmunoterapia contra el cáncer. También a epítopos peptídicos para linfocitos T citotóxicos (CTL) asociados a tumores, solos o en combinación con otros péptidos asociados a tumores que pueden servir como principios activos farmacéuticos en composiciones vacunales destinadas a estimular respuestas inmunitarias antitumorales. Además se refiere específicamente a varias secuencias peptídicas y sus variantes derivadas de moléculas antígenos leucocitarios humanos (HLA) de clase I y clase II de células tumorales humanas que pueden ser utilizadas en composiciones vacunales para desencadenar respuestas inmunitarias antitumorales.This refers to peptides, nucleic acids and cells intended for use in immunotherapeutic methods. In particular, it refers to immunotherapy against cancer. Also to peptide epitopes for cytotoxic T lymphocytes (CTL) associated with tumors, alone or in combination with other peptides associated with tumors that can serve as pharmaceutical active ingredients in vaccine compositions intended to stimulate antitumor immune responses. It also specifically refers to several peptide sequences and their variants derived from human leukocyte antigen (HLA) class I and class II human tumor cells that can be used in vaccine compositions to trigger antitumor immune responses.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462014849P | 2014-06-20 | 2014-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR100926A1 true AR100926A1 (en) | 2016-11-09 |
Family
ID=58699923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150101983A AR100926A1 (en) | 2014-06-20 | 2015-06-19 | IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR100926A1 (en) |
MA (1) | MA50590A (en) |
-
2015
- 2015-06-17 MA MA050590A patent/MA50590A/en unknown
- 2015-06-19 AR ARP150101983A patent/AR100926A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA50590A (en) | 2020-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20160531A (en) | NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, LIKE ACUTE MYELOGEN LEUKEMIA (LMA) | |
CU20160060A7 (en) | PEPTIDES, NUCLEIC ACIDS AND CELLS, USEFUL IN PERSONALIZED IMMUNOTHERAPY AGAINST VARIOUS CEREBRAL AND NEURONAL TUMORS | |
CO2018004865A2 (en) | Peptides and combinations of peptides for immunotherapy against chronic lymphocytic leukemia (llc) and other cancers | |
CR20160018A (en) | NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC) | |
CR20180174A (en) | NEW PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER | |
CR20170419A (en) | NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER CANCER AND OTHER TYPES OF CANCER. | |
AR103220A1 (en) | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (CHC) AND OTHER TYPES OF CANCER | |
TW201613956A (en) | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) | |
CY1124950T1 (en) | INNOVATIVE IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER INCLUDING SCLC | |
CO2017003772A2 (en) | Peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
CY1122083T1 (en) | INNOVATIVE IMMUNOTHERAPY AGAINST CERTAIN BLOOD TUMORS, SUCH AS ACUTE MYELOGIC LEUKEMIA (AML) | |
AR100926A1 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA | |
AR118181A2 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) | |
AR113131A2 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC) | |
AR101159A1 (en) | IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF THE BLOOD, LIKE THE ACUTE MYELOGEN LEUKEMIA (LMA) | |
MX2019013161A (en) | Personalized immunotherapy against several neuronal and brain tumors. | |
EA201990696A1 (en) | PERSONALIZED IMMUNOTHERAPY OF SEVERAL SPECIES OF NEURAL TUMORS AND BRAIN TUMORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |